Cite

HARVARD Citation

    Liu, G. et al. (2020). CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma. European journal of immunology. 50 (5), pp. 712-724. [Online]. 
  
Back to record